Solid Tumors clinical trials
Showing 751–800 of 1,133 active trials. Describe your situation to see which ones look like a fit.
- Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- DOAC - Dosing Options in AntiCoagulation Prophylaxis
- Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
- Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)
- PET [89Zr]DFO-starPEG in Solid Tumors
- Continuous Versus Intermittent cARdiac Electrical moNitorinG
- HP Pyruvate MRI in Cancers
- Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures
- Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
- First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging
- Imaging of Solid Tumors Using 18F-TRX
- A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
- A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
- Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- 64Cu-GRIP B in Patients With Advanced Malignancies
- Imaging of Solid Tumors Using FAP-2286
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
- Cancer Genetic Testing in Ethnic Populations
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Indocyanine Green (ICG) Guided Tumor Resection
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
- TCF-001 TRACK (Target Rare Cancer Knowledge) Study
- An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
- 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
- Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- Intravital Microscopy in Human Solid Tumors
- Identifying and Caring for Individuals With Inherited Cancer Syndrome
- Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
- SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
- A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
- Unified Network for Integrated Fluid Collection at Yale
- Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
- Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies
- A Study of MSK-TCR5 in People With Solid Tumor Cancers
- A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
- A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
- A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
- Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
- Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer
- Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
- Decoupling Immunotherapy Toxicity and Cancer Response
- Voices: Messages of Wisdom and Hope in the Face of Illness
- Impact of Physician Behavior on Cancer Distress
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.